Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Depei Wu

Showing results (181-190 of 579) with videos related to

Pageof 58
Sort By:
Zhonghua Yi Xue Za Zhi|January 10, 2015
[Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus]Tiemei Song, Guanghua Chen, Xiang Zhang, et al.
European Journal of Haematology|May 27, 2009
All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cellsHaiwen Huang, Depei Wu, Jinxiang Fu, et al.
International Journal of Hematology|June 16, 2017
FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantationShanhao Tang, Hongjie Shen, Xinliang Mao, et al.
Transplantation and Cellular Therapy|April 8, 2021
Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNetTanzhen Wang, Sifan Chen, Jia Chen, et al.
Annals of Hematology|April 13, 2021
HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplantJiaqian Qi, Rui Zhang, Chengsen Cai, et al.
Plos One|April 25, 2013
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemiaXiuli Wang, Haiping Dai, Qian Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
IL-1β and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administrationYong Liang, Shoubao Ma, Yanming Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic MicroangiopathyTingting Pan, Jiaqian Qi, Tao You, et al.
Frontiers in Oncology|December 13, 2023
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature reviewJiajie He, Rui Zou, Liqing Kang, et al.
British Journal of Haematology|May 25, 2026
Long-term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T-lymphoblastic lymphomaQian Cheng, Ying Zhu, Kaiyu Sheng, et al.
Pageof 58

Showing results (181-190 of 579) with videos related to

Sort By:
Pageof 58
Zhonghua Yi Xue Za Zhi|January 10, 2015
[Clinical outcomes of allogeneic hematopoietic stem cell transplantation patients with co-activation of cytomegalovirus and Epstein-Barr virus]Tiemei Song, Guanghua Chen, Xiang Zhang, et al.
European Journal of Haematology|May 27, 2009
All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cellsHaiwen Huang, Depei Wu, Jinxiang Fu, et al.
International Journal of Hematology|June 16, 2017
FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantationShanhao Tang, Hongjie Shen, Xinliang Mao, et al.
Transplantation and Cellular Therapy|April 8, 2021
Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNetTanzhen Wang, Sifan Chen, Jia Chen, et al.
Annals of Hematology|April 13, 2021
HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplantJiaqian Qi, Rui Zhang, Chengsen Cai, et al.
Plos One|April 25, 2013
EZH2 mutations are related to low blast percentage in bone marrow and -7/del(7q) in de novo acute myeloid leukemiaXiuli Wang, Haiping Dai, Qian Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2013
IL-1β and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administrationYong Liang, Shoubao Ma, Yanming Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2019
Circulating Heme Oxygenase-1 and Complement Activation in Transplant-Associated Thrombotic MicroangiopathyTingting Pan, Jiaqian Qi, Tao You, et al.
Frontiers in Oncology|December 13, 2023
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature reviewJiajie He, Rui Zou, Liqing Kang, et al.
British Journal of Haematology|May 25, 2026
Long-term outcomes after allogeneic versus autologous haematopoietic stem cell transplantation for T-lymphoblastic lymphomaQian Cheng, Ying Zhu, Kaiyu Sheng, et al.
Pageof 58